Search Results - Janni, W.

Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-n... by Meyer-Wilmes, Philipp (Author) , Huober, Jens (Author) , Untch, Michael (Author) , Blohmer, J. -U. (Author) , Janni, W. (Author) , Denkert, Carsten (Author) , Klare, P. (Author) , Link, T. (Author) , Rhiem, K. (Author) , Bayer, C. (Author) , Reinisch, M. (Author) , Bjelic-Radisic, V. (Author) , Zahm, Dirk-Michael (Author) , Hanusch, Claus Alexander (Author) , Solbach, C. (Author) , Heinrich, G. (Author) , Hartkopf, A. D. (Author) , Schneeweiss, Andreas (Author) , Fasching, Peter Andreas (Author) , Filmann, N. (Author) , Nekljudova, V. (Author) , Holtschmidt, J. (Author) , Stickeler, E. (Author) , Loibl, Sibylle (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer: original article by Geyer, Charles Edward, Jr. (Author) , Garber, J. E. (Author) , Gelber, R. D. (Author) , Yothers, G. (Author) , Taboada, M. (Author) , Ross, L. (Author) , Rastogi, P. (Author) , Cui, K. (Author) , Arahmani, A. (Author) , Aktan, G. (Author) , Armstrong, A. C. (Author) , Arnedos, M. (Author) , Balmaña, J. (Author) , Bergh, J. (Author) , Bliss, J. (Author) , Delaloge, S. (Author) , Domchek, S. M. (Author) , Eisen, A. (Author) , Elsafy, F. (Author) , Fein, L. E. (Author) , Fielding, A. (Author) , Ford, J. M. (Author) , Friedman, S. (Author) , Gelmon, K. A. (Author) , Gianni, L. (Author) , Gnant, M. (Author) , Hollingsworth, S. J. (Author) , Im, S.-A. (Author) , Jager, A. (Author) , Jóhannsson, Ó. Þ (Author) , Lakhani, S. R. (Author) , Janni, W. (Author) , Linderholm, B. (Author) , Liu, T.-W. (Author) , Loman, N. (Author) , Korde, L. (Author) , Loibl, S. (Author) , Lucas, P. C. (Author) , Marmé, Frederik (Author) , Martinez de Dueñas, E. (Author) , McConnell, R. (Author) , Phillips, K.-A. (Author) , Piccart, M. (Author) , Rossi, G. (Author) , Schmutzler, R. (Author) , Senkus, E. (Author) , Shao, Z. (Author) , Sharma, P. (Author) , Singer, C. F. (Author) , Španić, T. (Author) , Stickeler, E. (Author) , Toi, M. (Author) , Traina, T. A. (Author) , Viale, G. (Author) , Zoppoli, G. (Author) , Park, Y. H. (Author) , Yerushalmi, R. (Author) , Yang, H. (Author) , Pang, D. (Author) , Jung, K. H. (Author) , Mailliez, A. (Author) , Fan, Z. (Author) , Tennevet, I. (Author) , Zhang, J. (Author) , Nagy, T. (Author) , Sonke, G. S. (Author) , Sun, Q. (Author) , Parton, M. (Author) , Colleoni, M. A. (Author) , Schmidt, M. (Author) , Brufsky, A. M. (Author) , Razaq, W. (Author) , Kaufman, B. (Author) , Cameron, D. (Author) , Campbell, C. (Author) , Tutt, A. N. J. (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext

Therapiealgorithmen für das Mammakarzinom = Treatment algorithms for breast cancer by Blohmer, Jens-Uwe (Author) , Schneeweiss, Andreas (Author) , Bauerfeind, I. (Author) , Fehm, T. (Author) , Müller, V. (Author) , Thomssen, C. (Author) , Witzel, I. (Author) , Wöckel, A. (Author) , Janni, W. (Author) ,

• Verlag, lizenzpflichtig, Volltext

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program☆ by Müller, Volkmar (Author) , Banys-Paluchowski, M. (Author) , Friedl, T. W. P. (Author) , Fasching, P. A. (Author) , Schneeweiss, Andreas (Author) , Hartkopf, A. (Author) , Wallwiener, D. (Author) , Rack, B. (Author) , Meier-Stiegen, F. (Author) , Huober, J. (Author) , Rübner, M. (Author) , Hoffmann, O. (Author) , Müller, L. (Author) , Janni, W. (Author) , Wimberger, P. (Author) , Jäger, B. (Author) , Pantel, K. (Author) , Riethdorf, S. (Author) , Harbeck, N. (Author) , Fehm, T. (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext

Toxicity assessment of a phase III study evaluating FEC-Doc and FEC-Doc combined with gemcitabine as an adjuvant treatment for high-risk early breast cancer: the SUCCESS-A trial =... by Schröder, Lennard (Author) , Rack, B. (Author) , Sommer, H. (Author) , Koch, J. G. (Author) , Weissenbacher, T. (Author) , Janni, W. (Author) , Schneeweiss, Andreas (Author) , Rezai, M. (Author) , Lorenz, R. (Author) , Jäger, B. (Author) , Schramm, A. (Author) , Häberle, L. (Author) , Fasching, P. A. (Author) , Friedl, T. W. P. (Author) , Beckmann, M. W. (Author) , Scholz, C. (Author) ,

• Resolving-System, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext